Screener
Clorox CLX Cash & Equivalents
Cash & Equivalents at other companies
Other financials
Where this comes from
Reported directly by Clorox in its filing.
Tagged under the XBRL concept us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents.
The source filing: Clorox’s 10-Q, filed April 30, 2026.
- Filed
- Apr 30, 2026, 4:48 PM EDT
- Fiscal quarter
- Q3 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0000021076-26-000019
| Line item | Nine months ended / 3/31/2026 | Nine months ended / 3/31/2025 |
|---|---|---|
| Cash dividends paid to noncontrolling interests | — | (16) |
| Issuance of common stock for employee stock plans and other | (16) | 30 |
| Net cash provided by (used for) financing activities | 857 | (645) |
| Effect of exchange rate changes on cash, cash equivalents and restricted cash | (2) | (2) |
| Net increase (decrease) in cash, cash equivalents and restricted cash | 1,017 | 22 |
| Cash, cash equivalents and restricted cash: | ||
| Beginning of period | 170 | 207 |
| End of period | $1,187 | $229 |
Item 1. Financial Statements
FAQ
- What is Clorox's cash & equivalents?
- Clorox (CLX) reported cash & equivalents of $1.19B in Q1 2026.
- How has Clorox's cash & equivalents changed year-over-year?
- Clorox's cash & equivalents increased by 418.3% year-over-year, from $229M to $1.19B.
- What is the long-term trend for Clorox's cash & equivalents?
- Over 4 years (2021 to 2025), Clorox's cash & equivalents has grown at a -14.9% compound annual growth rate (CAGR), from $324M to $170M.
- What does cash & equivalents mean?
- Cash on hand plus highly liquid investments with maturities of three months or less at purchase — treasury bills, money market funds, and commercial paper.
Ask your AI about Clorox's cash & equivalents.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude